Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity Tunis El Manar

About this trial

The Erector Spinae Plane (ESP) block or spinal erector block was first described in September 2016 by a Canadian team. It's a block that was initially used for the treatment of chronic thoracic neuropathic pain. The ESP block is one of the inter-fascicular blocks and it's an easy-to-perform technique.In the literature, it has been reported that Lumbar ESPB provides effective analgesia after a hip surgery.

The purpose of this prospective randomized study was to compare the analgesic effects of the ultrasound-guided lumbar Erector Spinae Plane block on postoperative pain management versus the multimodal analgesia after total hip arthroplasty.

Eligibility criteria

Qualifiers

primary total hip arthroplasty with lateral approach and under general anesthesia .

Disqualifiers

• Contraindication or refusal to regional anesthesia

Contraindication to non-steroidal anti-inflammatory (NSAID's)

Allergy to opioids

Allergy to paracetamol

Trial design

Treatments tested in this trial

  • Lumbal Erector Spinae Plane Block
  • intravenous pain killers

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators